AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Explore which real-world use cases BTC or ETH enables today. This quick intro highlights practical applications and adoption trends to help you decide where to focus.
28,454 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A new analysis finds the pandemic born cohort of first and second graders continues to lag in math and reading compar...
Longbridge's Q1 results set a quarterly high and eclipsed its 2025 full-year profit, highlighting strong reverse-mort...
US spot Bitcoin ETFs posted $227 million in net outflows last week, marking six straight weeks of selling. Analysts s...
President Trump announces plans for the first new U.S. oil refinery in nearly five decades, backed by Reliance Indust...
Figma stock shows signs of a potential rebound as profitability improves and AI-driven features gain traction, even a...
Shareholders allege a controlling investor pressured Red Lobster to endure an endless shrimp push, turning a popular ...
Airbnb's path through 2026 to 2030 hinges on travel demand, new services, and pricing power. This report lays out sce...
Lucid jumps 9%, NIO climbs 7%, and Tesla rises about 4% as the broader EV complex gets a fresh bid amid demand signal...
Palantir shares cooled in late June as investors weigh AI-led growth against valuation. Analysts remain divided, with...
FCC Chairman Brendan Carr signals a renewed push to enforce public-interest standards on TV stations, warning that li...
KeyBanc raises NVIDIA's price target to $300 ahead of May earnings, pointing to Blackwell and Rubin as near-term cata...